Irinotecan in combination with 5-fluorouracil and folinic acid or with cisplatin in patients with advanced gastric or esophageal-gastric junction adenocarcinoma: results of a randomized phase II study. - Pozzo,C.; Barone,C.; Szanto,J. (Ann Oncol, 2004)